Jan Gettemans is full professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is research on nanobodies (single domain antibodies) and their implementation in a diverse array of (bio)medical settings.
Emmeric Tanghe is a part-time professor at Ghent University and imec. His field of research is computational neuroscience. His group builds biophysical models of neurons and neuronal networks that are modulated by neurostimulation techniques (electromagnetic, optogenetic, ultrasonic). The goal is to find stimulation paradigms and protocols that, to a certain degree, can reverse the pathologic firing behavior caused by neurological diseases. We collaborate with preclinical research groups for in-vitro and in-vivo validation of our models.
Frank Speleman is professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences. His main focus is the study of perturbed gene regulatory processes in paediatric cancer, more specifically neuroblastoma and T-ALL.
Nico Callewaert is group leader and director of the VIB-UGent Center for Medical Biotechnology and full professor in biochemistry and biotechnology at Ghent University. His research interests focus on the invention of technologies for medicine, proteins and sugars.
Kevin Braeckmans is Full Professor at Ghent University, faculty of Pharmaceutical Sciences. He is co-director of the Lab. Of General Biochemistry and Physical Pharmacy and group leader of the Biophotonics Research Group. His focus is on light-based technologies for investigating and facilitating drug delivery to cells and tissues, including for cell therapy applications.
Prof. Jolanda van Hengel is heading the medical cell biology group. Her group focuses on the in vitro engineering of functional myocardium that mimics human heart tissue for analysis of myocardial function. Also her group tries to obtain a suitable stem cell type for in vitro meat production.
Frauke Coppieters is assistant professor within RARE-MED, a Ghent University multidisciplinary consortium for basic and translational research on precision medicine for rare diseases (Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences). Her research focuses on retinal disease modelling and new genetic therapies for inherited blindness.
Sarah Vergult is an assistant professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University. She is partner of the Ghent University RARE-MED consortium, that aims to address missing heritability in rare disorders. She studies the role of the noncoding part of the genome in rare diseases, in particular in neurodevelopmental disorders and implements tools to functionally characterize candidate genes for neurodevelopmental disorders.
Prof. Debbaut holds a 100% professorship at the Biommeda research group within Ghent University and focuses mainly on the use of computational biofluid mechanics as a tool for personalized medicine by studying applications related to organ perfusion, mass transport phenomena in the context of targeted and locoregional drug delivery, and lymph flow.